Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relacorilant Phase 2 in Endogenous Cushing's Syndrome
NCT02804750Phase 2Completed
- Sponsor
- Corcept Therapeutics
- Start
- Jun 2016
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of relacorilant in Cushing's syndrome, sponsored by Corcept Therapeutics. Started Jun 2016; status: completed.
02
Drugs
relacorilant
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT02804750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02804750.